Product Description
Product Name: Nexavar 200 mg Tablet
Active Ingredient: Sorafenib Tosylate
Strength: 200 mg
Form: Oral Tablet
Category: Anticancer / Tyrosine Kinase Inhibitor (TKI)
Indication: Hepatocellular Carcinoma (Liver Cancer), Renal Cell Carcinoma (Kidney Cancer), Differentiated Thyroid Carcinoma
Nexavar 200 mg Tablet contains Sorafenib, a multi-kinase inhibitor that targets several enzymes involved in tumor growth and angiogenesis (blood vessel formation). It is used for the treatment of advanced liver cancer (hepatocellular carcinoma), advanced kidney cancer (renal cell carcinoma), and certain types of thyroid cancer that are resistant to radioactive iodine therapy.
